New Real-World study tests triple inhaler for better asthma control

NCT ID NCT06786767

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 281 adults with asthma for 6 months to see if a triple-combination inhaler (BDP/FF/G) improves symptom control in everyday life. Participants had asthma for at least 3 years and were not well controlled on their current treatment. The main goal was to measure changes in the Asthma Control Test score, which rates how well asthma is managed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AIPSACA Dr. Talyat Cholak

    Razgrad, Bulgaria

  • AIPSMC Dr. Svetlan Mihaylov

    Stara Zagora, Bulgaria

  • AIPSMCPP Dr. Bilyana Ivanova

    Vratsa, Bulgaria

  • AIPSMCPP Dr. Elina Smilkova

    Blagoevgrad, Bulgaria

  • AIPSMCPP Dr. Nikolay Lichev V. Tarnovo

    Veliko Tarnovo, Bulgaria

  • ASIMPIDPP Dr. Veselin Kalfov

    Haskovo, Bulgaria

  • Group practice for specialized medical care - Asthma Center Pleven

    Pleven, Bulgaria

  • IPASMC Dr. Kostadinka Sotirova

    Pazardzhik, Bulgaria

  • MHAT Svoge

    Svoge, Bulgaria

  • Medical Center Denitza

    Montana, Bulgaria

  • Medical Center Hipocrat

    Gabrovo, Bulgaria

  • Medical Center St. Ivan Rilski

    Vidin, Bulgaria

  • Medical Center Third Policlinic

    Stara Zagora, Bulgaria

  • Medical Center Viva Phenix

    Dobrich, Bulgaria

More trials for these conditions

Other studies related to the condition(s) this trial covers.